Medigene Presents at CAR-TCR Summit Europe Showcasing Unique Approach for Development of Differentiated TCR-T Therapies
February 29, 2024 06:00 ET
|
Medigene AG
Multiple members of management as expert speakers including Prof. Dr. Dolores Schendel, Chief Scientific Officer of Medigene, Dr. Barbara Lösch, Head of Technology & Innovation and Dr. Kirsty...
Medigene to Present at Upcoming Conferences
February 19, 2024 08:00 ET
|
Medigene AG
Planegg/Martinsried, February 19, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell...
GeoVax Announces Multiple Patent Issuances and Allowances
February 13, 2024 09:00 ET
|
GeoVax, Inc.
Intellectual Property Assets Strengthened for Cancer Immunotherapy Programand for Marburg Virus and HIV Vaccines ATLANTA, GA, Feb. 13, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc....
Medigene Announces Indication Selection for the Clinical Development of its Lead 3rd Generation TCR-T Therapy Program in Solid Tumors
February 12, 2024 08:00 ET
|
Medigene AG
Gastric cancer, ovarian cancer, myxoid/round cell liposarcoma and synovial sarcoma selected as initial clinical indications for lead program MDG1015MDG1015 is a first-in-class, third generation TCR-T...
Flow Cytometry in Oncology and Immunology Market Set for Growth Amid Increasing Global Cancer Prevalence
January 24, 2024 13:24 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Flow Cytometry in Oncology and Immunology Market Report 2023" report has been added to ResearchAndMarkets.com's offering. As per the latest...
Contract Research Organization Market revenue to hit USD 108 Billion by 2035, says Research Nester
January 15, 2024 06:00 ET
|
Research Nester
New York , Jan. 15, 2024 (GLOBE NEWSWIRE) -- The global contract research organization market size is slated to expand at 7% CAGR between 2023 and 2035. The market is poised to garner a revenue of...
Medigene AG to attend at the 42nd Annual J.P. Morgan Healthcare Conference
December 19, 2023 08:00 ET
|
Medigene AG
Planegg/Martinsried, December 19, 2023. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell...
Zenas BioPharma Strengthens Executive Leadership with Appointment of Jennifer Fox as Chief Business Officer and Chief Financial Officer and Tanya Fischer, M.D., PhD. as Head of R&D and Chief Medical Officer
December 04, 2023 08:00 ET
|
Zenas BioPharma
WALTHAM, Mass., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of inflammation and...
Single Cell Sequencing Market Size to Reach USD 6,193.01 Million in 2032
November 30, 2023 03:25 ET
|
Emergen Research
Vancouver, Nov. 30, 2023 (GLOBE NEWSWIRE) -- The global single-cell sequencing market is expected to reach USD 6,193.01 Million by 2032, according to a new report by Emergen Research. Single-cell...
Medigene AG Announces Prioritization of Pipeline and Resource Allocation as well as Extension of Cash Runway
November 21, 2023 12:05 ET
|
Medigene AG
Lead program MDG1015 on track for CTA/IND approval in 2H 2024Prioritization of pipeline to accelerate the advancement of Medigene’s maturing KRAS-libraryProjected cash runway extended to Q1 2025....